| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.017 | 0.7 |